(Medical Xpress) -- Viruses are notorious for entering cells, taking over their internal machinery, and turning them into virus manufacturing centers. But new research by Howard Hughes Medical Institute investigator Peter ...
May 3, 2011
0
0
Writing in the journal Stem Cells Translational Medicine, an international research team, led by physician-scientists at University of California San Diego School of Medicine, describe a new method for delivering neural precursor ...
Jan 29, 2020
0
9
A test that can detect the presence of antibodies to the SARS-CoV-2 virus in the blood of human patients is described in Nature Medicine. This assay, tested in 16 patients, may help to identify individuals whose plasma contains ...
May 13, 2020
0
2
We've known since the turn of the 20th century that some infectious diseases are a major risk for developing specific cancers. More worryingly, about one-sixth of cancers worldwide are attributable to infectious agents. Globally, ...
Aug 26, 2016
0
2
A common genetic change is associated with a reduced risk of severe COVID-19 infection, highlighting a potential target for drugs in early treatment.
Feb 10, 2022
0
77
A study appearing next week in the journal Nature Communications offers some good news in the search for antiviral drugs for hard-to-treat diseases. Researchers have identified a potential new drug candidate against enterovirus ...
Sep 22, 2020
0
43
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.
Jul 21, 2020
0
8
Urinary tract infections (UTIs) frequently recur due to bacteria constructing safe havens within the host. While infection is frequently caused by uropathogenic Escherichia coli that originates in the gut, little is known ...
Jul 10, 2020
0
5
Emory Vaccine Center researchers say they have identified the Achilles heel of SARS-CoV-2, the virus that causes COVID-19.
Sep 26, 2023
0
82
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein. This key protein enables the human ...
Jan 13, 2013
0
0
